Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,718 Cr
down ₹12.5 Cr vs Sep 2023
- Stocks held
- 26
- unchanged
- Top 10 weight
- 68.4%
- of the portfolio in its ten largest
- Cash & debt
- 1.3%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 15
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In October 2023 it disclosed 26 stocks worth ₹1,718 Cr, down ₹12.5 Cr from Sep 2023. Its largest positions were Sun Pharmaceutical Industries Limited (12.9%), IPCA Laboratories Limited (8.7%), Cipla Limited (8.4%); the ten largest together made up 68.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 73.3% of its equity. Cash and debt stood at 1.3%. Compared with Sep 2023 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
10%
Holds more stocks than 10% of peers
Cash
14%
Holds more cash than 14% of peers
What these mean: concentration · cash
Holdings in October 2023
Download CSVEvery line the fund disclosed, with the change against Sep 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 12.91% | down 0.73 pts | ₹222 Cr | down ₹14.3 Cr | Trimmed |
| IPCA Laboratories Limited | 8.69% | up 1.07 pts | ₹149 Cr | up ₹17.4 Cr | Added |
| Cipla Limited | 8.42% | down 0.34 pts | ₹145 Cr | down ₹7 Cr | Trimmed |
| Suven Pharmaceuticals Limited | 7.81% | up 0.98 pts | ₹134 Cr | up ₹16.1 Cr | Added |
| Lupin Limited | 7.18% | down 0.22 pts | ₹123 Cr | down ₹4.7 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 5.23% | down 0.30 pts | ₹89.7 Cr | down ₹5.9 Cr | Trimmed |
| Alembic Pharmaceuticals Limited | 5.21% | down 0.43 pts | ₹89.5 Cr | down ₹8 Cr | Trimmed |
| Procter & Gamble Health Limited | 4.71% | up 0.02 pts | ₹81 Cr | down ₹16 L | Held |
| Concord Biotech Limited | 4.18% | up 0.26 pts | ₹71.7 Cr | up ₹4 Cr | Added |
| Alkem Laboratories Limited | 4.07% | up 0.16 pts | ₹69.8 Cr | up ₹2.2 Cr | Added |
| Globus Medical Inc | 3.81% | down 0.29 pts | ₹65.5 Cr | down ₹5.5 Cr | Trimmed |
| Vijaya Diagnostic Centre Limited | 3.48% | up 0.54 pts | ₹59.8 Cr | up ₹8.9 Cr | Added |
| Zydus Lifesciences Limited | 2.76% | up 0.04 pts | ₹47.4 Cr | up ₹33 L | Added |
| Indoco Remedies Limited | 2.43% | down 0.05 pts | ₹41.7 Cr | down ₹1.1 Cr | Trimmed |
| Intuitive Surgical Inc | 2.39% | down 0.25 pts | ₹41 Cr | down ₹4.6 Cr | Trimmed |
| Aarti Drugs Limited | 2.02% | down 0.30 pts | ₹34.6 Cr | down ₹5.4 Cr | Trimmed |
| Mankind Pharma Limited | 1.97% | down 0.05 pts | ₹33.9 Cr | down ₹1 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 1.93% | up 0.10 pts | ₹33.2 Cr | up ₹1.6 Cr | Added |
| Unichem Laboratories Limited | 1.82% | up 0.38 pts | ₹31.2 Cr | up ₹6.3 Cr | Added |
| Kovai Medical Center and Hospital Limited | 1.71% | down 0.02 pts | ₹29.3 Cr | down ₹55 L | Trimmed |
| Taro Pharmaceutical Industries Limited | 1.47% | up 0.22 pts | ₹25.3 Cr | up ₹3.5 Cr | Added |
| Abbott Laboratories | 1.45% | down 0.02 pts | ₹24.9 Cr | down ₹54 L | Trimmed |
| Cash, TREPS & receivables | 1.26% | down 0.58 pts | ₹21.6 Cr | down ₹10.1 Cr | Trimmed |
| MedPlus Health Services Limited | 0.89% | up 0.03 pts | ₹15.2 Cr | up ₹43 L | Added |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 0.85% | down 0.12 pts | ₹14.7 Cr | down ₹2.1 Cr | Trimmed |
| Jupiter Life Line Hospitals Limited | 0.58% | down 0.02 pts | ₹10 Cr | down ₹41 L | Trimmed |
| Illumina Inc | 0.45% | down 0.11 pts | ₹7.7 Cr | down ₹1.9 Cr | Trimmed |
| Pfizer Limited | 0.35% | up 0.01 pts | ₹6 Cr | up ₹11 L | Added |
What changed, Sep 2023 to Oct 2023
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- IPCA Laboratories Limitedup ₹17.4 Cr (+1.07% pts)
- Suven Pharmaceuticals Limitedup ₹16.1 Cr (+0.98% pts)
- Vijaya Diagnostic Centre Limitedup ₹8.9 Cr (+0.54% pts)
- Unichem Laboratories Limitedup ₹6.3 Cr (+0.38% pts)
- Concord Biotech Limited ₹4 Cr (+0.26% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2023, the weight rose most in Pharmaceuticals (+0.3 pts) and Pharmaceuticals & Biotechnology (+0.2 pts), and fell most in Healthcare Equipment & Supplies (−0.6 pts).
- Pharmaceuticals5.5% → 5.8%+0.3 pts
- Pharmaceuticals & Biotechnology73.1% → 73.3%+0.2 pts
- Healthcare Equipment & Supplies6.9% → 6.3%−0.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2020 | Oct 2022 | Apr 2023 | Jul 2023 | Sep 2023 | Oct 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 63.5% | 61.4% | 69.5% | 72.4% | 73.1% | 73.3% |
| Healthcare Services | 21.4% | 23.3% | 15.1% | 12.8% | 11.7% | 11.7% |
| Healthcare Equipment & Supplies | 3.8% | 6.4% | 6.4% | 5.7% | 6.9% | 6.3% |
| Pharmaceuticals | 7.6% | 5.6% | 5.7% | 5.6% | 5.5% | 5.8% |
| Insurance | 3.6% | 2.4% | 2.1% | 2.3% | 1.9% | 2.0% |
| Retailing | — | 1.0% | 1.2% | 1.3% | 0.9% | 0.9% |
Allocation in Oct 2023change vs Sep 2023
- Pharmaceuticals & Biotechnology (14)73.3%▲ 0.2 pts
- Healthcare Services (5)11.7%
- Healthcare Equipment & Supplies (2)6.3%▼ 0.6 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Oct 2023
1.3%
▼ 0.6 pts vs Sep 2023
- Cash alone
- 1.2%
- cash and net receivables
- A year earlier
- 1.7%
- Oct 2022 · now ▼ 0.4 pts
- Last 12 months
- <0.1% – 4.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.